inert 1 MG Oral Tablet
- RxCUI
- 748797
- RxNorm name
- inert 1 MG Oral Tablet
- Display name
- inert 1 MG Oral Tablet
- Full name
- inert 1 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Preferred Pharmaceuticals, Inc. | 90240210-0bca-4a55-99dc-19f2b40d8e3f | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 748797 |
| SLYND | DROSPIRENONE | Exeltis USA, Inc. | db32bc55-f295-4d87-9dbb-0a2f45573dcf | 2026-08-27 | Warnings, Adverse reactions | 748797 |
| Isibloom | DESOGESTREL AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 4a8f278f-f505-4537-8deb-74e8927df8c6 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Redpharm Drug | 57d1d945-9fc9-4e79-e063-6294a90a738a | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 748797 |
| norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | 2385591b-70ee-0577-e063-6394a90a9357 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Desogestrel and Ethinyl Estradiol | DESOGESTREL AND ETHINYL ESTRADIOL | Camber Pharmaceuticals, Inc. | 78454ebf-f1a3-4ca0-b32e-88c51bc57773 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIORELE | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6422dcc3-959a-4590-9ca8-9dcb58e68253 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| MONO-LINYAH | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 2ec8f18f-297c-405f-b191-a40767366bad | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Turqoz | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | e7a05138-91a5-4c66-a915-614576e0805a | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Kurvelo | LEVONORGESTREL AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 752f525e-1838-4058-9ab7-2c2d91f86dfd | 2026-05-20 | Boxed warning, Warnings | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Apotex Corp. | 9187a357-e95d-4733-9627-f19522b86373 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Wera | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | 638e4f36-1a27-4220-8ec9-3fa9d9b36c11 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Dasetta 7/7/7 | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | da52e74a-1baf-4a33-a068-b49176700320 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Vestura | DROSPIRENONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals, Inc. | c6f63cc0-11b0-4320-a9ef-5bd5c9b16fd5 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Cryselle | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f73ece43-6b5f-4abb-ba6d-4d62775f2f8e | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 35c6507c-555a-45ed-aaf6-8695831de71a | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIENVA TM | LEVONORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f6825c1a-ba78-47aa-9622-12e59517ab1a | 2026-03-03 | Warnings, Adverse reactions | 748797 |
| drospirenone and ethinyl estradiol | DROSPIRENONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6edead7f-a41f-4d0b-a27a-b2047ed4eea0 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Lutera | LEVONORGESTREL AND ETHINYL ESTRADIOL | Dr. Reddys Laboratories Inc. | 47fc432b-2259-47d2-bba9-5e3aae583990 | 2026-02-13 | Warnings, Adverse reactions | 748797 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fa32e05b-c86d-4743-aee5-be3fc515152b | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | ALYACEN 1/35(Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) | 20260101 |
| e80714f4-cdfe-4d60-a4e1-b8c7b184cc46 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Necon ® (Norethindrone and Ethinyl Estradiol Tablets, USP, 0.5 mg/0.035 mg) | 20250909 |
| f0288c8d-6ca0-41fa-93f2-b6c2d073891f | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Azurette ® Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and 0.01 mg | 20240625 |
| fb636d42-cc1d-47f7-974d-c97c79207f3e | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Zovia ® 1/35 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP) Rx only | 20240601 |
| f8961550-d103-8ee6-e053-6294a90a7571 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Desogestrel and ethinyl estradiol and ethinyl estradiol tablets | 20240422 |
| 7ca41896-abb1-43c2-99f8-7b3584ac8d7d | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use OCELLA safely and effectively. See full prescribing information for OCELLA. OCELLA (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20230703 |
| a522aff5-b02f-4e18-bf59-40bb0399e6fe | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use Nymyo safely and effectively. See full prescribing information for Nymyo. Nymyo (norgestimate/ethinyl estradiol tablets) for oral use. Initial U.S. Approval:1989 | 20221208 |
| b13800f2-618f-468d-b8a5-2fc00595db61 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use Tri-Nymyo safely and effectively. See full prescribing information forTri-Nymyo. Tri-Nymyo (norgestimate/ethinyl estradiol tablets) for oral use. Initial U.S. Approval: 1989 | 20221208 |
| 643b9e90-2bfc-411d-89cc-344add0e4205 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use MonoNessa or TriNessa safely and effectively. See full prescribing information for MonoNessa and TriNessa. MonoNessa ® and TriNessa ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20190412 |
| 8a2c68c4-9cf9-48c5-9b97-e38e7c5e0a03 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use MonoNessa or TriNessa safely and effectively. See full prescribing information for MonoNessa and TriNessa. MonoNessa ® and TriNessa ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20190109 |
| 7cf2b373-c8f3-4568-953d-15d70a125182 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Velivet ™ (desogestrel and ethinyl estradiol tablets, USP - triphasic regimen) Rx only PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. | 20120516 |
| 96af95c4-ed8b-450b-920b-bc12678f3584 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20120315 |
| c7de193c-d730-4f63-aa23-178b5f400967 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | ORTHO TRI-CYCLEN ® TABLETS ORTHO-CYCLEN ® TABLETS (norgestimate/ethinyl estradiol) | 20120227 |
| 994cefc2-0724-4b56-a816-ccdabef5492e | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Kelnor™ 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets, USP) | 20110124 |
| 18c143b6-2f83-4dcb-b84a-855739212f25 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15mg/0.03 mg | 20260403 |
| 47fc432b-2259-47d2-bba9-5e3aae583990 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Rx only | 20260213 |
| 241fb1e2-c0da-47b8-b502-2cb17976d7c0 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Cyred EQ ® (Desogestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg) Rx only | 20250605 |
| 1aff28b0-93eb-5e44-9164-d76ffd08cd59 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Rx only VALTYA 1/50 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg/50 mcg) Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases . | 20250205 |
| 207dfcf6-5239-c907-e5fe-35372da57dd9 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | VALTYA 1/35 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg/35 mcg) | 20250205 |
| 24abb5e1-5be4-87e7-404c-d8c2db25ffd0 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE . INTROVALE ® (levonorgestrel and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1982 | 20241015 |
| 1f3ead9b-4794-4e5d-e063-6394a90ad049 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Chateal EQ ® (Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg) Rx only | 20240809 |
| 1cfc748b-2b54-6a6c-e063-6294a90a2930 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240711 |
| 51e4270a-1b91-4ff8-9a50-ffe49204b6b4 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | 20230221 | |
| 5f3dedb9-a500-4e21-8ffa-0d942243c790 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use TRI-LO-MILI® safely and effectively. See full prescribing information for TRI-LO-MILI. TRI-LO-MILI (norgestimate and ethinyl estradiol) tablets for oral use Initial U.S. Approval: 1989 | 20230101 |
| 5b684f8f-9610-4449-a213-f70bb4a04b8b | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Nortrel ® 7/7/7 (norethindrone and ethinyl estradiol tablets USP, 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) | 20220801 |
| 38d8c4ec-790b-4ff5-9d08-0ae230491e47 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use MILI safely and effectively. See full prescribing information for MILI. MILI TM (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20190102 |
| 0c81daae-b83c-4444-9ad1-425518bf32d8 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets | 20170815 |
| 5f40763f-c0c1-44a3-a6c0-b7fe59b7d88f | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Myzilra ® (levonorgestrel and ethinyl estradiol tablets USP)—TRIPHASIC REGIMEN Rx only Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. | 20160201 |
| 3f9cdcf0-a4f5-472f-a70d-9eb835299fce | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Cyclafem ™ 7/7/7 (norethindrone and ethinyl estradiol tablets USP) | 20160120 |
| 47864f8c-0b43-47ff-a1df-d8ff57d3e4e5 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | DELYLA™ (Levonorgestrel and Ethinyl Estradiol Tablets, USP) Rx only | 20140325 |
| 684602ed-06c6-4633-b587-135c616f091e | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | WATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only | 20120710 |
| 252bb64c-e551-47fe-add9-242a94502bdf | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | WATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only | 20120618 |
| 70441908-2e6c-4fdc-9544-e93a5a7223d4 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Nortrel™ 7/7/7 (norethindrone and ethinyl estradiol tablets, USP 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) | 20120601 |
| 14dd2d66-a414-4ac7-8d08-db0f7e54e326 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | WATSONPHARMA Revised: April 2007 IN-5351/S Lutera® (Levonorgestrel and Ethinyl Estradiol Tablets USP) Rx only | 20120501 |
| 69e66f08-be0b-4120-9a30-333b34ad3507 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | TriNessa ® Tablets (norgestimate and ethinyl estradiol) | 20110913 |
| 2de68f9e-fa13-4b87-84f9-dbb73883ba40 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Necon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only | 20110315 |
| 709031e4-4c20-4ea7-beff-6c459709a433 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | 20110128 | |
| 6c095eec-8d92-4b07-8f9e-84bb8c9bc3f8 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | ENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen) | 20110126 |
| 3fbcd7d8-cc53-4dbb-8edc-451acadc472c | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use Natazia safely and effectively. See full prescribing information for Natazia. Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for oral use Initial U.S. Approval: 2010 | 20101005 |
| 3c247e9d-fff8-40e8-a9d3-88adee3426e2 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 1 | Zenchent® 0.4/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.4 mg/0.035 mg, 28-Day) | 20100813 |